EpilepsiaPub Date : 2026-11-16DOI: 10.1002/epi.70559
Ana Carolina Coan, Julia Jacobs, Jithangi Wanigasinghe, Elaine Wirrell, Simona Balestrini, Ingrid E Scheffer, Stephane Auvin, Kelly G Knupp, Rima Nabbout, Nathalie Jette, Francesco Brigo, Kette Valente
{"title":"Antiseizure medication use in self-limited epilepsies of childhood: A scoping review by the ILAE Pediatric Medical Therapies Task Force.","authors":"Ana Carolina Coan, Julia Jacobs, Jithangi Wanigasinghe, Elaine Wirrell, Simona Balestrini, Ingrid E Scheffer, Stephane Auvin, Kelly G Knupp, Rima Nabbout, Nathalie Jette, Francesco Brigo, Kette Valente","doi":"10.1002/epi.70559","DOIUrl":"https://doi.org/10.1002/epi.70559","url":null,"abstract":"<p><strong>Objective: </strong>Self-limited focal epilepsies (SeLFEs) of childhood, including self-limited epilepsy with centrotemporal spikes (SeLECTS), self-limited epilepsy with autonomic seizures (SeLEAS), childhood occipital visual epilepsy (COVE), and photosensitive occipital lobe epilepsy (POLE), are common pediatric epilepsy syndromes with heterogeneous clinical management. We performed a scoping review to synthesize evidence regarding the use, effectiveness, safety, and discontinuation of antiseizure medications (ASMs) in children with SeLFEs.</p><p><strong>Methods: </strong>Nine databases were searched from inception to January 2026. Eligible studies included original research reporting ASM-related outcomes in children with SeLFEs. PRISMA-ScR (Preferred Reporting Items of Systematic Reviews and Meta-Analyses, extension for scoping reviews) guidance was followed.</p><p><strong>Results: </strong>Sixty-two studies met eligibility criteria, including 11 randomized controlled trials (RCTs). Most studies evaluated SeLECTS (6171 participants), whereas substantially fewer investigated SeLEAS (n = 348), COVE (n = 91), or POLE (n = 26). Evidence was highly heterogeneous and consisted predominantly of retrospective observational studies. In SeLECTS, reported 12-month seizure freedom rates after ASM treatment were approximately 72% across studies, although estimates varied considerably. Evidence for SeLEAS, COVE, and POLE was limited and derived mainly from small retrospective cohorts with heterogeneous methodologies and outcome definitions. Failure of first-line ASM therapy occurred in approximately 30% of patients. Adverse events were reported in approximately 22% of treated children and infrequently led to treatment discontinuation. RCTs generally reported similar seizure outcomes across multiple ASMs, although many trials were limited by small sample sizes and open-label designs.</p><p><strong>Significance: </strong>Current evidence suggests that children with SeLFEs often achieve seizure control with ASM treatment and that adverse effects are generally manageable. However, the overall certainty of evidence remains limited because of methodological heterogeneity, predominance of retrospective studies, and limited randomized data. Important evidence gaps remain regarding the need for ASM treatment, optimal treatment duration, and timing of medication withdrawal.</p>","PeriodicalId":11768,"journal":{"name":"Epilepsia","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2026-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149417306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EpilepsiaPub Date : 2026-11-16DOI: 10.1002/epi.70598
Emanuele Cerulli Irelli, Marco Perulli, Carlo Di Bonaventura, Domenica I Battaglia
{"title":"Temporal evolution of electroencephalographic hallmarks in Lennox-Gastaut syndrome: Beyond diagnostic timing.","authors":"Emanuele Cerulli Irelli, Marco Perulli, Carlo Di Bonaventura, Domenica I Battaglia","doi":"10.1002/epi.70598","DOIUrl":"https://doi.org/10.1002/epi.70598","url":null,"abstract":"","PeriodicalId":11768,"journal":{"name":"Epilepsia","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2026-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149417308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EpilepsiaPub Date : 2026-11-16DOI: 10.1002/epi.70596
Giancarlo Di Gennaro
{"title":"When is Lennox-Gastaut syndrome diagnosed? The temporal logic of a longitudinal diagnosis.","authors":"Giancarlo Di Gennaro","doi":"10.1002/epi.70596","DOIUrl":"https://doi.org/10.1002/epi.70596","url":null,"abstract":"","PeriodicalId":11768,"journal":{"name":"Epilepsia","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2026-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149417309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EpilepsiaPub Date : 2026-11-16DOI: 10.1002/epi.70560
Albert J Becker, Klaus Ferdinand Gärditz
{"title":"Individualized antisense oligonucleotide therapy for SCN2A-related developmental epileptic encephalopathy beyond seizure control: A word of caution regarding the development of precision medicine neuropharmaceuticals.","authors":"Albert J Becker, Klaus Ferdinand Gärditz","doi":"10.1002/epi.70560","DOIUrl":"https://doi.org/10.1002/epi.70560","url":null,"abstract":"","PeriodicalId":11768,"journal":{"name":"Epilepsia","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2026-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149417307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EpilepsiaPub Date : 2026-11-14Epub Date: 2026-08-11DOI: 10.1002/epi.70417
Pilar Bosque-Varela, Panagiota-Eleni Tsalouchidou, Petra Levicka, Lara Wadi, Elizabeth R. Blackwood, Eugen Trinka, Birgit Frauscher
{"title":"Clinical significance of subclinical seizures in epilepsy presurgical evaluation: A systematic review and meta-analysis","authors":"Pilar Bosque-Varela, Panagiota-Eleni Tsalouchidou, Petra Levicka, Lara Wadi, Elizabeth R. Blackwood, Eugen Trinka, Birgit Frauscher","doi":"10.1002/epi.70417","DOIUrl":"10.1002/epi.70417","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>Subclinical seizures (SCSs) remain an understudied aspect of presurgical evaluation in patients with drug-resistant epilepsy (DRE), with uncertain prevalence, distribution among epilepsy types, and predictive value for surgical outcomes. This systematic review and meta-analysis aims to explore the occurrence of SCSs, their concordance with the seizure-onset zone (SOZ), and their association with postoperative seizure outcomes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A systematic search of Medline, Embase, and Web of Science was performed to identify studies reporting SCSs during scalp electroencephalography (EEG) monitoring or intracranial EEG (iEEG) monitoring in patients with DRE undergoing epilepsy surgery. Data on SCS prevalence, concordance with SOZ, and postoperative outcomes were extracted. Pooled proportions and odds ratios (ORs) were estimated using random-effects generalized linear mixed models. Subgroup analyses evaluated the proportions of SCSs in temporal vs extratemporal epilepsy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Thirteen studies comprising 1174 patients met the inclusion criteria. The pooled prevalence of SCSs was 32% (95% confidence interval [CI] 8–73) during scalp EEG monitoring and 50% (95% CI 38–62) during iEEG monitoring. Concordant SCSs with SOZ occurred in 37% of patients undergoing iEEG. Non-concordant SCSs were associated with a nearly fivefold higher odds of poor postoperative seizure control (OR 4.82, 95% CI 1.80–12.96; <i>p</i> = 0.002). SCSs were more frequent in temporal lobe epilepsy than in extratemporal epilepsy (57% vs 44%, <i>p</i> = 0.046). Within temporal lobe epilepsy, the highest prevalence was observed in the mesiotemporal region (69%). Overall, the presence of SCSs alone was not associated with a poor outcome, but the spatial non-concordance with the SOZ was highly predictive for poor seizure outcome.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Significance</h3>\u0000 \u0000 <p>SCSs are common in presurgical evaluation, particularly in temporal lobe epilepsy. Although their presence alone is not prognostic, non-concordant SCSs are associated with worse postoperative outcomes. Systematic assessment, especially using iEEG, may improve delineation of the epileptogenic zone and surgical planning in DRE.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11768,"journal":{"name":"Epilepsia","volume":"67 11","pages":"5653-5665"},"PeriodicalIF":5.6,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/epi.70417","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148711076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EpilepsiaPub Date : 2026-11-14Epub Date: 2026-08-05DOI: 10.1002/epi.70413
Chao Huang, Ge Tan, Junming Li, Honglei Xu, Ling Liu
{"title":"Reduced rapid eye movement sleep proportion is associated with anxiety and depressive symptoms in newly diagnosed epilepsy","authors":"Chao Huang, Ge Tan, Junming Li, Honglei Xu, Ling Liu","doi":"10.1002/epi.70413","DOIUrl":"10.1002/epi.70413","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>This study was undertaken to examine the associations between rapid eye movement (REM) sleep proportion, depressive and anxiety symptoms, and quality of life (QOL) in newly diagnosed epilepsy (NDE).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A total of 104 treatment-naive people with NDE and 50 age−/gender-matched healthy controls were enrolled. Assessments included polysomnography and the Chinese version of the Neurological Disorders Depression Inventory for Epilepsy (C-NDDI-E), Generalized Anxiety Disorder-7, and Quality of Life in Epilepsy Inventory-31 (QOLIE-31). Eighty-eight patients completed 12-month QOL follow-up. Cross-sectional analyses included Spearman correlation and mediation (PROCESS Model 4, 5000 bootstraps). Longitudinal analyses used logistic and linear regression with sequentially added covariates, and least absolute shrinkage and selection operator for variable selection.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Baseline REM sleep correlated negatively with C-NDDI-E (<i>r</i><sub><i>s</i></sub> = −.512, <i>p</i> < .001) and positively with QOLIE-31 (<i>r</i><sub><i>s</i></sub> = .394, <i>p</i> < .001). C-NDDI-E correlated negatively with QOLIE-31 (<i>r</i><sub><i>s</i></sub> = −.461, <i>p</i> < .001). Depressive symptoms partially mediated the REM–QOL association (indirect effect = .253, 52.5% of total effect). Anxiety did not mediate REM–QOL but partially mediated REM–depression. Longitudinally, the REM–12-month QOL association was significant after adjusting for age and gender (odds ratio [OR] = 1.113, <i>p</i> = .005), but not after additionally adjusting for baseline C-NDDI-E (OR = .968, <i>p</i> = .542). No independent linear association remained (<i>B</i> = .087, 95% confidence interval = –.119 to .292, <i>p</i> = .405).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Significance</h3>\u0000 \u0000 <p>Reduced REM sleep is associated with increased depressive severity in NDE. Depressive symptoms mediate both cross-sectional and prospective REM–QOL associations, with little independent effect of REM sleep on QOL. Anxiety does not directly mediate REM–QOL but partially mediates REM–depression.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11768,"journal":{"name":"Epilepsia","volume":"67 11","pages":"5729-5742"},"PeriodicalIF":5.6,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148677070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Low-intensity focused ultrasound neuromodulation for drug-resistant epilepsy: A randomized, sham-controlled crossover trial","authors":"Chien-Chen Chou, Yen-Cheng Shih, Yi-Hsiu Chen, Po-Tso Lin, Chun-Fu Lin, Po-Chun Chu, Hao-Li Liu, Cheng-Chia Lee, Hsiang-Yu Yu","doi":"10.1002/epi.70404","DOIUrl":"10.1002/epi.70404","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>This study was undertaken to evaluate the safety, feasibility, and efficacy of low-intensity focused ultrasound (LIFU) as a noninvasive neuromodulation technique in patients with drug-resistant epilepsy (DRE).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>In this pilot, single-blind, randomized sham-controlled crossover trial, 12 patients with DRE underwent both LIFU and sham stimulation in a randomized sequence, targeting the seizure onset zone (SOZ), each followed by a 4-week observation period. Seizure frequency was analyzed as proportional change from baseline using linear mixed-effects models. An open-label extension phase evaluated longitudinal seizure outcomes following LIFU. Safety assessments included neurological examinations, magnetic resonance imaging (MRI), and neuropsychological and quality of life (QOL) measures.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>During the crossover phase, LIFU did not significantly reduce seizure frequency compared with sham (estimate = .49, 95% confidence interval [CI] = −.04 to 1.01, <i>p</i> = .068). No period or sequence effects were observed. Conversely, during the open-label extension phase, seizure frequency demonstrated a significant longitudinal reduction following LIFU (β = −14.0 percentage points per month, 95% CI = −22.2 to −5.8, <i>p</i> = .001). Post-LIFU MRI showed no structural lesions. No significant changes were observed in anxiety, depression, or QOL scores. There were only transient mild-to-moderate adverse events reported, without serious complications.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Significance</h3>\u0000 \u0000 <p>LIFU neuromodulation targeting the SOZ is safe and well tolerated. Although the primary crossover analysis did not demonstrate a statistically significant antiseizure effect, delayed seizure reduction during the extended follow-up suggests potential sustained neuromodulatory effects. Larger parallel-group trials with longer observation periods are warranted.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11768,"journal":{"name":"Epilepsia","volume":"67 11","pages":"5715-5728"},"PeriodicalIF":5.6,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/epi.70404","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148653172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EpilepsiaPub Date : 2026-11-14Epub Date: 2026-08-22DOI: 10.1002/epi.70441
Victor Karpychev, Rebecca W. Roth, Kathryn A. Davis, Daniel L. Drane, Anto I. Bagić, Patricia C. Dugan, Heath R. Pardoe, Alexandra Parashos, Nealen G. Laxpati, Ruben Kuzniecky, Leonardo Bonilha, Ezequiel Gleichgerrcht
{"title":"Distributed functional cross-network connectivity of the epileptogenic zone predicts late seizure relapse in temporal lobe epilepsy","authors":"Victor Karpychev, Rebecca W. Roth, Kathryn A. Davis, Daniel L. Drane, Anto I. Bagić, Patricia C. Dugan, Heath R. Pardoe, Alexandra Parashos, Nealen G. Laxpati, Ruben Kuzniecky, Leonardo Bonilha, Ezequiel Gleichgerrcht","doi":"10.1002/epi.70441","DOIUrl":"10.1002/epi.70441","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>Although many patients with temporal lobe epilepsy achieve seizure freedom in the first post-operative year, the likelihood of long-term seizure freedom declines substantially over time. Late seizure relapse may reflect ongoing epileptogenicity, potentially driven by persistent epileptic activity arising from the epileptogenic zone. We hypothesized that its more distributed connectivity profile across brain networks would distinguish patients experiencing late relapse.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We prospectively enrolled 209 patients with drug-resistant temporal lobe epilepsy across six centers who underwent destructive surgery, pre-operative diffusion-weighted magnetic resonance imaging (MRI), and/or resting-state functional MRI. To isolate network mechanisms related to late relapse rather than early surgical failure, we focused on patients who achieved seizure freedom after the first post-operative year. After two post-operative years, these patients were stratified into long-term seizure freedom (SF–SF) and late relapse (SF–NSF). We delineated post-operative resections to localize epileptogenic zones and quantified their network properties using graph-theory metrics–betweenness centrality and participation coefficient. Patient graph-theory metrics were standardized relative to normative connectomes derived from 362 healthy controls. We evaluated associations between patient graph-theory metrics and long-term outcomes using Firth's bias-reduced regressions and permutation testing.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Fifty-four patients with diffusion-weighted MRI (SF-SF = 37, SF-NSF = 17) and 30 patients with functional MRI (SF-SF = 19, SF-NSF = 11) met the inclusion criteria. Greater functional MRI-derived participation coefficient of resections was associated with late relapse, reflecting a more distributed connectivity profile across networks. In a post hoc analysis, lower diffusion-weighted MRI-derived betweenness centrality of the epileptogenic hippocampus was associated with late relapse. Effects were confirmed by patient-level and anatomy-preserving permutations.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Significance</h3>\u0000 \u0000 <p>Long-term outcomes in temporal lobe epilepsy depend not only on accurate localization and removal of epileptogenic tissue but also on how its connectivity is distributed across brain networks before surgery. Pre-operative cross-network connectivity of the epileptogenic zone may represent a biomarker of late relapse.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11768,"journal":{"name":"Epilepsia","volume":"67 11","pages":"5679-5691"},"PeriodicalIF":5.6,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148789645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}